tert-Butyl 2-(cyclopropanecarbonyl)hydrazinecarboxylate, 95.0%, 1g

1-benzyl-N-[(3-methylthiophen-2-yl)methyl]piperidin-4-amine dihydrochloride, 95.0%, 2g

2-Amino-5-(4-methylpiperazin-1-yl)benzoic acid, 98%, 100mg

4-chlorobutanamide, 95.0%, 5g

tert-Butyl ((3S,4R)-4-fluoropyrrolidin-3-yl)carbamate, 98%, 250mg

4-(Dimethoxymethyl)-2-methylpyrimidine, 95.0%, 1g

(S)-6-CHLORO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE HCL, 95.0%, 1g

2-Fluoro-5-methoxyaniline, 95.0%, 10g

Screw vials free-standing sterile, 2 ml, 200 Piece(s)

4-(TERT-BUTOXYCARBONYL)-3-METHYLMORPHOLINE-3-CARBOXYLIC ACID, 95.0%, 5g

N-Methyl-1,1-diphenylmethanamine, 99.0%, 1g

tert-Butyl N-[1-(pyridin-2-yl)piperidin-4-yl]carbamate, 95.0%, 250mg

Mandatory signs in accordance with ISO 7010, Protective apron required, 100 mm, 1 piece